Blog

What the 2026 AHA/ASA guideline means for community hospitals deciding whether a stroke patient stays or transfers. On October 8,...

Harnessing AI to transform diagnosis and care in lung cancer, interstitial lung disease, pulmonary hypertension, bronchiectasis, and more. Written by...

By Matan Banin, Senior Software Engineer at Viz.ai Context: What Viz does and why speed matters Imagine a neurologist getting...

By Chris Mansi, MD, CEO, Viz.ai and Andrew M. Ibrahim, Chief Clinical Officer, Viz.ai At a recent closed-door session at...

On a Monday morning, Dr. Hayner — Critical Care Pulmonologist at TriHealth, Director of the Medical-Surgical ICU, and a national...

By Andrew M. Ibrahim MD, MSc, Chief Clinical Officer at Viz.ai and George D. Zuidema Professor, University of Michigan Much...

By Andrew M. Ibrahim, MD, MSc, Chief Clinical Officer, Viz.ai As a practicing physician, I often hear the narrative that...

By Orit Alul, Chief Architect at Viz.ai Healthcare is undergoing a data transformation. At the heart of this shift are...

As healthcare professionals (HCPs) increasingly adopt AI in their daily decision-making, the way life sciences companies engage must evolve. Quickly....